These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 478436)

  • 1. Modification by oral contraceptives in rat of 14C acetate incorporation into platelet lipids.
    Ciavatti M; Renaud S
    Horm Metab Res; 1979 Jul; 11(7):441-4. PubMed ID: 478436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral contraceptives and blood platelets].
    Davenas E; Ciavatti M; Poitevin B; Aubin M
    Homeopath Fr; 1985; 73(5):299-305. PubMed ID: 12281246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive and Platelet lipid biosynthesis in female rats: dose-response relationship.
    Ciavatti M; Davenas E; Michel G; Renaud S
    Lipids; 1982 Feb; 17(2):111-4. PubMed ID: 7087684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of cholesterol and cholesterol precursors in platelets of female rats treated with oral contraceptives.
    Ciavatti M; Michel G; Renaud S
    Biochim Biophys Acta; 1980 Nov; 620(2):297-307. PubMed ID: 7437455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
    Nash AL; Cornish EJ; Hain R
    Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced platelet aggregation by oral contraceptives: effect of PG synthetase inhibitors.
    Sudhir S; Gupta LC; Singh J; Garg KN
    Indian J Physiol Pharmacol; 1982; 26(3):231-4. PubMed ID: 6816736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill.
    Sadurska B; Tacconi MT; di Minno G; Roncaglioni MC; Pangrazzi J; Donati MB; Bizzi A; Silver MJ
    Thromb Haemost; 1981 Apr; 45(2):150-3. PubMed ID: 7256698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel.
    Larsson-Cohn U; Wallentin L; Zador G
    Horm Metab Res; 1979 Jul; 11(7):437-40. PubMed ID: 225252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of acetylsalicylic acid on human platelet function in normal volunteers and in women using a combined oral contraceptive regime.
    Baele G; Thiery M; Vermeulen A; Barbier F
    Thromb Haemost; 1976 Dec; 36(3):623-7. PubMed ID: 1037156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
    Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ethinyl oestradiol and megestrol acetate on carbohydrate metabolism in rabbits.
    Gaitonde BB; Kulkarni HJ
    Indian J Med Res; 1977 Aug; 66(2):223-35. PubMed ID: 924594
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of contraceptive steroids on plasma lipoprotein metabolism in female rats (II).
    Köse K; Doğan P; Ozesmi C
    Biochem Mol Biol Int; 1993 Jun; 30(2):245-52. PubMed ID: 8364406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in plasma lipids caused by oral contraceptives].
    Kaffarnik H
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
    Winkler UH; Sudik R
    Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies on oral glucose tolerance and serum lipids under the influence of a new oral contraceptive (SH B 209 AB: 2 mg cyproterone acetate + 0.05 mg ethinyl estradiol), the combination D-norgestrel/ethinyl estradiol and in a control group (author's transl)].
    Schillinger E; Gerloff C; Wellershoff S; Wendt H; Lachnit-Fixson U
    Arzneimittelforschung; 1976; 26(12):2242-5. PubMed ID: 1037282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects, on the endometrium, of a new oral contraceptive: Physiostat].
    Delacroix P
    Rev Fr Gynecol Obstet; 1977; 72(7-9):583-5. PubMed ID: 905717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical aspects of a new, very low dose combination contraceptive].
    Mladenović D; Grcić R; Pestelek B; Kapor M
    Fortschr Med; 1978 Apr; 96(13):723-6. PubMed ID: 631715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
    Lepot MR; Gaspard UJ
    Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of hormonal contraceptives on parameters of lipid metabolism (author's transl)].
    Carol W; Klinger G
    Zentralbl Gynakol; 1980; 102(22):1273-82. PubMed ID: 6164181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.